Abstract:Objective: To explore the mechanism that miR-29b and B7H3 regulate the polarization of macrophages and thus affect the differentiation of CD4+T. Methods: 1. PBMC was extracted from peripheral blood mononuclear cells of children with asthma and normal children in the affiliated Children's Hospital of Soochow University, and RNA was extracted and reverse transcribed. The expression of miR-29b and B7H3mRNA was determined by real-time quantitative polymerase chain reaction (Q-PCR). The family history of asthma and history of allergic diseases were collected. 2.THP-1 cells were induced into macrophages, miR-29b interference, miR-29b overexpression and normal control were induced by LV526, LV527 and NC virus infection. After 24 hours of culture, the cells were collected to detect the expression of STAT3 and B7H3 genes and proteins. 3. It was verified that STAT3 was the target gene of miR-29b: after inoculating THP-1 cells and culturing with PMA with final concentration of 50ng/ml for 6 hours, the macrophages without PMA were cultured for 24 hours, then the macrophages infected by LV528, LV529 and NC virus were induced to form miR-29b interference, miR29b overexpression and normal control group. Luciferase analysis was performed at 48 hours to verify that STAT3 was the target gene of miR-29b. STAT3- 3'UTR luciferase reporter gene plasmids were constructed and divided into three groups: "miR-29b+ STAT3- 3'UTR", "miR-29b+STAT3-mut-3'UTR" and "miR-29b+luciferase empty load". 4. Macrophages with different treatments were co-cultured with initial T cells for 3 days. The relative expressions of T-bet, GATA3 and ROR-γt were detected by Q-PCR. Result: 1. The incidence of allergic disease in the acute attack group (68％) was higher than that in the other two groups (34.8％, 33.3％), and the family history of asthma in the normal group (0％) was much lower than that in the other two groups (52％, 60.9％). The difference was statistically significant (P<0.05). 2.The expression of B7H3 in PBMC in acute attack group was higher than that in non-acute attack group and normal group. The expression of miR-29b in PBMC in normal group was significantly higher than that in non-acute attack group and acute attack group (P< 0.0001). The expression of miR-29b in non-acute attack group was significantly higher than that in acute attack group (P= 0.007). 3. After silencing the expression of miR-29b, IL-4Rα, IL-4, IL-5, IL-13 and CD206 of macrophages increased significantly, while IFN- γ decreased, suggesting that miR-29b can promote the polarization of macrophages to M2. 4. The overexpression of miR-29b, STAT3 and B7H3 gene and protein level in macrophages decreased, while the increase of miR-29b, STAT3 and B7H3 gene and protein expression was inhibited. 5. There was a significant positive correlation between the expression of STAT3 and B7H3mRNA in macrophages (r = 0.9737, P< 0.0001). 6. STAT3 is the target gene of miR-29b. 7. Co-culture of macrophages with CD4+T cells can promote the differentiation of primary T cells, namely Th 0 cells, into Th2, and the promoting effect of macrophages with down-regulation of miR-29b is more obvious. Conclusion: The expression of miR-29b in PBMC of children with asthma is lower than that of normal children, while the expression of B7H3 is higher than that of normal children. It is speculated that miR-29b has a protective effect on children with asthma, while B7H3 aggravates the inflammatory response. Down-regulation of miR-29b, in macrophages can promote macrophages to M2 polarization, increase the expression of B7H3 and STAT3 in macrophages, make Th0 cells differentiate into Th2 cells, and aggravate the inflammatory response in patients with asthma.

Luteolin activates M2 macrophages and suppresses M1 macrophages by upregulation of hsa_circ_0001326 in THP-1 derived macrophages

Luteolin Alters Macrophage Polarization to Inhibit Inflammation

Luteolin transforms the polarity of bone marrow-derived macrophages to regulate the cytokine storm

MiR-127 Modulates Macrophage Polarization and Promotes Lung Inflammation and Injury by Activating the JNK Pathway

Luteolin transforms the BMDM polarity to regulate the expression of inflammatory factors

Polarized activation affects iron metabolism in macrophages

Lupeol suppresses plasminogen activator inhibitor-1-mediated macrophage recruitment and attenuates M2 macrophage polarization

Hesperetin derivative-12 (HDND-12) regulates macrophage polarization by modulating JAK2/STAT3 signaling pathway

Luteolin Regulates the Differentiation of Regulatory T Cells and Activates IL-10-Dependent Macrophage Polarization against Acute Lung Injury

Effects of long non-coding RNA MALAT1 on macrophage polarization

LncRNA AK089514/miR-125b-5p/TRAF6 axis mediates macrophage polarization in allergic asthma

Effect of macrophage polarization regulated by miR-29b, B7H3 on CD4+T cell differentiation in asthma

Up-regulation of MiR-145-5p promotes the growth and migration in LPS-treated HUVECs through inducing macrophage polarization to M2

IL-16 regulates macrophage polarization as a target gene of mir-145-3p

Lipoxin A4 regulates M1/M2 macrophage polarization via FPR2–IRF pathway

IL‐21 Regulates Macrophage Activation in Human Monocytic THP‐1‐derived Macrophages

Luteolin Inhibits Obesity-Associated Adipose Tissue Macrophage Polarization through Protein Kinase C(PKC) Pathway

Luteolin inhibits autophagy in allergic asthma by activating PI3K/Akt/mTOR signaling and inhibiting Beclin-1-PI3KC3 complex.

Mir-511-3p Limits Allergic Inflammation Through M2 Macrophage Polarization And Modulating Ccl2 Expression

Curcumin Modulates Macrophage Polarization Through the Inhibition of the Toll-Like Receptor 4 Expression and Its Signaling Pathways

Cadherin-26 drives macrophage alternative activation via suppressing STUB1-mediated IL-4Rα ubiquitination in asthma